Implementation of AI functionality in the clinical laboratory testing system
First written in FY2024. 1 of 4 entries say "Advanced", first in FY2025-H1. Latest entry: 2026-05-12.
No other company in this theme has enough history to compare yet.
- 2026-05-12Cited as achievedEarnings presentation
「April: Began developing and selling AI-equipped medical package software」
The company restated the start of development and sales of AI-equipped medical package software as an achievement under its medium-term management plan. - FY2025AchievedAnnual report
「In the medical field, we announced and began selling the “CLIP-Version5.1 AI” clinical laboratory testing system in April 2025, incorporating the AI-based system-operation support function under development.」
The implementation of AI functions in the CLIP series reached the specific milestone of announcement and sales launch in April 2025. R&D expenses for the consolidated fiscal year were ¥17,382 thousand. - FY2025-H1AdvancedAnnual report
「Group-wide R&D expenses during the interim consolidated accounting period were ¥8,686 thousand, all related to R&D of products for sale conducted in the medical field of Industrial and Distribution Services. Specifically, these were development costs aimed at implementing functions in our CLIP series clinical laboratory testing system that use AI to support system operation, where both accuracy and speed are required.」
R&D toward implementing AI functions in the CLIP series continued, with ¥8,686 thousand recorded as R&D expenses during the interim consolidated accounting period. - FY2024First statedAnnual report
「For the “CLIP series,” we are pursuing development aimed at implementing functions that use AI to support system operation in clinical laboratory testing, where both accuracy and speed are required.」
The policy of implementing AI-based system-operation support functions in the proprietary CLIP series has been newly specified.